ERBB2 and triple-negative breast carcinoma: For the triple-negative breast cancer (TNBC) subgroup, recurrence and metastasis events were seen in 11 (16.4%) cases in the HER-2 ultra-low group and 7 (9.2%) cases in the HER-2 low group.